The potential benefits of glucagon-like-peptide-1 receptor agonists (GLP1-RAs) have continued to mount exponentially in recent years, with suggested roles in combating chronic disease and mental illness (Drucker, 2024; Hendershot and colleagues, 2025; Jerlhag,... ...

请注册登录后继续浏览